UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 2
Quarterly report pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2008
Commission file number 0-28288
CARDIOGENESIS CORPORATION
(Exact name of small business issuer as specified in its charter)
| |
|
|
| California
|
|
77-0223740 |
|
|
|
|
| (State of incorporation or organization)
|
|
(I.R.S. Employer |
|
|
|
Identification Number) |
11 Musick
Irvine, California 92618
(Address of principal executive offices)
(949) 420-1800
(Issuer’s telephone number)
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act during the past 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated
filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange
Act. (Check one):
| |
|
|
|
|
|
|
| Large accelerated filer o
|
|
Accelerated filer
o
|
|
Non-accelerated filer o
|
|
Smaller reporting company
þ |
|
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act).
Yes o No þ
State the number of shares outstanding of each of the issuer’s classes of common equity as of
the latest practicable date:
45,274,395 shares of Common Stock, no par value, as of April 30, 2008.
TABLE OF CONTENTS
EXPLANATORY NOTE
This form 10-Q/A (Amendment No. 2) amends the Form 10-Q filed on May 15, 2008 by Cardiogenesis
Corporation with respect to the quarter ended March 31, 2008, as further amended by Amendment No. 1
thereto, filed on July 7, 2008. This amendment is being filed in order to correct Exhibits 31.1
and 31.2 which inadvertently omitted certain required language. Other than the changes to these
two Exhibits, no other portion of the Form 10-Q has been amended.
2